Product no. 161555 Active
Get quote
Catalog Search results 161555
161555
Order / Price
Price on request

Acclaim PepMap100 C8

by Dionex

 

The members of the Acclaim® PepMap™ and Acclaim PepMap RSLC families are designed to separate peptides and proteins efficiently. These silica-based stationary phases have virtually zero silanophilic activity, resulting in minimal peak tailing. The Acclaim PepMap columns can be operated TFA-free, making them ideal for LC-MS based biomolecular analysis.

Acclaim® PepMap100 C8 is an excellent alternative for the Acclaim PepMap100 C18, when separating very hydrophobic peptides (e.g., non-tryptic peptides). It is available with 3 or 5 µm particles, with 100 Å pore sizes, and in capillary and micro formats.

Application areas:
Peptides
Specification
Vendor Dionex Particle Size
Brand Acclaim PepMap100 C8 Length
Modifification Silica/C8 Internal Diameter
Mode Reversed-Phase Pore size 100
Similar columns Columns with same mode & modification — across all brands
VendorBrandModeModification Int. diam.LengthParticlesPoresPrice
Princeton Chromatography Inc. PrincetonSPHER C8-300 Reversed-Phase Silica/C8 3.0 mm 150 mm 5.0 μm 300 Å On request
Vertical Chromatography VertiSep EPS C8 Reversed-Phase Silica/C8 21.2 mm 250 mm 5.0 μm 100 Å On request
Welch Materials Ultisil LP-C8 Reversed-Phase Silica/C8 4.6 mm 250 mm 5.0 μm 120 Å On request
Orochem Reliasil C8 90 Reversed-Phase Silica/C8 4.6 mm 250 mm 5.0 μm 90 Å On request
PerkinElmer Brownlee SPP C8 Reversed-Phase Silica/C8 3.0 mm 50 mm 2.7 μm On request
Princeton Chromatography Inc. PrincetonSPHER C8-60 Reversed-Phase Silica/C8 3.0 mm 100 mm 3.0 μm 60 Å On request
Sepax Technologies Sepax Bio 300 C8 Reversed-Phase Silica/C8 0.75 mm 150 mm 3.0 μm 300 Å On request
SiliCYCLE SiliaChrom AQ C8 Reversed-Phase Silica/C8 3.0 mm 50 mm 3.0 μm 100 Å On request
Customer feedback

No customer reviews yet. Be the first to share your experience!

Advertise With Us

Reach thousands of HPLC scientists and researchers. Fill in your details and our team will contact you shortly.